Follow the 에스디생명공학 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에스디생명공학 has recorded 42 insider filings. The latest transaction was filed on 24 December 2025 (Sale). Among the most active insiders: 수성자산운용. The full history is accessible without an account.
42
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
38 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Listed on the XKRX market, 에스디생명공학 is a company focused on the health and pharmaceutical sector. It specializes in the development of innovative biopharmaceutical solutions.